Cerenome, Inc.

CNSY ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-22.7M $-22.0M $-18.7M $-37.4M $-26.2M $-32.3M $-32.5M $-27.5M
Depreciation & Amortization $2.2M $1.2M $1.1M $779.0K $1.6M $933.0K $855.0K $931.0K
Depreciation $900.0K $700.0K $700.0K $594.0K $1.6M $741.0K $618.0K $710.0K
Amortization $1.2M $584.0K $397.0K $185.0K $49.0K $192.0K $221.0K —
Stock-Based Compensation $753.0K $1.1M $2.0M $3.1M $3.6M $3.9M $3.3M $3.1M
Net Cash from Operating Activities $-18.1M $-19.5M $-20.5M $-30.3M $-34.6M $-32.2M $-35.3M $-23.6M
Investing Activities
Capital Expenditures $295.0K $67.0K $611.0K $764.0K $519.0K $1.2M $560.0K $610.0K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-1.4M — — $-1.3M $3.7M $-1.2M $-560.0K $-1.3M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $16.8M — — — $20.8M $22.2M $20.1M $64.7M
Net Change in Cash $-3.0M $-1.8M $-284.0K $-884.0K $-10.2M $-11.2M $-15.7M $39.8M
Free Cash Flow $-18.4M $-19.6M $-21.1M $-31.1M $-35.1M $-33.4M $-35.9M $-24.2M
← Newer Page 2 of 3 Older →